Results 141 to 150 of about 184,107 (180)

Efficacy of Conventional and Novel Tyrosine Kinase Inhibitors for Uncommon <i>EGFR</i> Mutations-An In Vitro Study. [PDF]

Cells
Oiki H, Suda K, Hamada A, Fujino T, Obata K, Kobayashi Y, Sakai K, Fukuda S, Ohara S, Ito M, Soh J, Nishio K, Mitsudomi T, Tsutani Y.   +13 more
europepmc   +1 more source

Explainable AI Model Reveals Informative Mutational Signatures for Cancer-Type Classification. [PDF]

Cancers (Basel)
Wagner J, Oldenburg J, Nath N, Simm S.
europepmc   +1 more source

Bayesian multi-study non-negative matrix factorization for mutational signatures. [PDF]

Genome Biol
Grabski IN, Trippa L, Parmigiani G.
europepmc   +1 more source

In Silico Discovery of a Novel Potential Allosteric PI3Kα Inhibitor Incorporating 3-(2-Chloro-5-fluorophenyl)isoindolin-1-one to Target Head and Neck Squamous Cell Carcinoma. [PDF]

Biology (Basel)
Jia W, Cheng X.
europepmc   +1 more source

Identification of CD159A as a prognostic and immune biomarker in kidney renal clear cell carcinoma. [PDF]

Sci Rep
Zhang J, Li X, Yu X, Jiang W, He X, Mei C, Ou C.   +6 more
europepmc   +1 more source

Mutational signatures and kataegis in pediatric B-cell precursor acute lymphoblastic leukemia. [PDF]

Hemasphere
Gunnarsson R, Yang M, Biloglav A, Lundin-Ström KB, Lilljebjörn H, Castor A, Fioretos T, Olsson-Arvidsson L, Paulsson K, Johansson B.   +9 more
europepmc   +1 more source

Landscape of TET2 Mutations: From Hematological Malignancies to Solid Tumors. [PDF]

Cancer Med
Hawking ZL, Allan JM.
europepmc   +1 more source

HLA class II-restricted T cell epitopes in public neoantigens of ESR1 and PIK3CA in breast cancer. [PDF]

BMC Cancer
Ando Y, Miyadera H, Bando H, Hashimoto S, Noguchi E, Hara H.   +5 more
europepmc   +1 more source

Genomic alterations in normal breast tissues preceding breast cancer diagnosis. [PDF]

Breast Cancer Res
Dai J, Rozenblit M, Li X, Shan NL, Wang Y, Mane S, Marczyk M, Pusztai L.   +7 more
europepmc   +1 more source

Exploring the mutational spectrum of key kinase genes PIK3CA, BRAF, EGFR, ALK and ROS1 in oral squamous cell carcinoma. [PDF]

BMC Cancer
Nawab F, Naeem W, Fatima S, Ali A, Khalil AT, Mehmood A, Fazeel M, Ahmad H, Alorini M, Khan M, Khan IA, Irfan M, Khurram SA.   +12 more
europepmc   +1 more source